Clinical Trials Directory

Trials / Completed

CompletedNCT04217655

Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Xuzhou Central Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Investigators aim to compare the diagnostic accuracy and radiation exposure between low-dose and standard-dose computed tomography-guided core needle biopsy for lung nodules.

Detailed description

At present, low-dose scanning protocol is widely used in computed tomography-guided interventions because these procedures usually require repeat scans, which causes more radiation exposure to the patients. Computed tomography-guided core needle biopsy is widely used in diagnosis of lung nodules with an overall diagnostic accuracy of 93%-97%. Compared with the large lung lesions, computed tomography-guided core needle biopsy for lung nodules might require more scanning to adjust the position of needle tip. Therefore, it might expose the patients to more radiation. However, studies regarding computed tomography-guided core needle biopsy for lung nodules are still lacking. In this study, investigators aim to compare the diagnostic accuracy and radiation exposure between low-dose and standard-dose computed tomography-guided core needle biopsy for lung nodules.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLow-dose computed tomographyRadiation dose under the low-dose protocol computed tomography (120 kilovolt, 15 milliampere seconds)
DIAGNOSTIC_TESTStandard-dose computed tomographyRadiation dose under the standard-dose protocol computed tomography (120 kilovolt, 150 milliampere seconds)

Timeline

Start date
2020-06-01
Primary completion
2020-12-31
Completion
2021-12-28
First posted
2020-01-03
Last updated
2021-12-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04217655. Inclusion in this directory is not an endorsement.